Sook-Bin Woo, D.M.D., B.D.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukoplakia, Oral | 14 | 2022 | 54 | 6.330 |
Why?
|
| Mouth Diseases | 20 | 2022 | 253 | 5.750 |
Why?
|
| Mouth Neoplasms | 20 | 2022 | 609 | 5.470 |
Why?
|
| Osteonecrosis | 21 | 2022 | 236 | 4.440 |
Why?
|
| Mouth Mucosa | 22 | 2021 | 432 | 4.270 |
Why?
|
| Keratosis | 7 | 2021 | 84 | 3.690 |
Why?
|
| Jaw Diseases | 14 | 2020 | 91 | 3.670 |
Why?
|
| Diphosphonates | 19 | 2016 | 627 | 3.460 |
Why?
|
| Odontogenic Tumors | 7 | 2021 | 42 | 2.980 |
Why?
|
| Oral Ulcer | 12 | 2021 | 101 | 2.530 |
Why?
|
| Mandibular Diseases | 10 | 2016 | 125 | 2.510 |
Why?
|
| Lichen Planus, Oral | 8 | 2022 | 52 | 2.270 |
Why?
|
| Tongue | 6 | 2022 | 408 | 2.170 |
Why?
|
| Precancerous Conditions | 9 | 2022 | 944 | 1.990 |
Why?
|
| Mouth | 6 | 2020 | 413 | 1.960 |
Why?
|
| Bone Density Conservation Agents | 12 | 2011 | 796 | 1.800 |
Why?
|
| Tongue Diseases | 5 | 2021 | 71 | 1.790 |
Why?
|
| Tongue Neoplasms | 5 | 2022 | 177 | 1.190 |
Why?
|
| Palate, Hard | 5 | 2017 | 56 | 1.170 |
Why?
|
| Epstein-Barr Virus Infections | 4 | 2021 | 558 | 1.150 |
Why?
|
| Gingival Diseases | 3 | 2021 | 32 | 1.140 |
Why?
|
| Jaw | 5 | 2017 | 94 | 1.090 |
Why?
|
| Alveolar Process | 3 | 2020 | 289 | 1.070 |
Why?
|
| Diagnosis, Differential | 37 | 2021 | 13276 | 1.010 |
Why?
|
| Graft vs Host Disease | 15 | 2018 | 2827 | 1.000 |
Why?
|
| Palatal Neoplasms | 4 | 2017 | 38 | 1.000 |
Why?
|
| Stomatitis | 4 | 2021 | 266 | 0.990 |
Why?
|
| Foreign-Body Reaction | 2 | 2014 | 161 | 0.970 |
Why?
|
| Papillomavirus Infections | 4 | 2017 | 1516 | 0.940 |
Why?
|
| Mandibular Neoplasms | 3 | 2020 | 133 | 0.940 |
Why?
|
| CREST Syndrome | 1 | 2022 | 6 | 0.910 |
Why?
|
| Leukemia, Eosinophilic, Acute | 1 | 2021 | 6 | 0.900 |
Why?
|
| Carcinoma in Situ | 3 | 2021 | 820 | 0.880 |
Why?
|
| Bronchogenic Cyst | 1 | 2021 | 29 | 0.850 |
Why?
|
| Burning Mouth Syndrome | 4 | 2019 | 31 | 0.840 |
Why?
|
| Salivary Gland Diseases | 2 | 2019 | 42 | 0.820 |
Why?
|
| Lichenoid Eruptions | 1 | 2020 | 19 | 0.820 |
Why?
|
| Herpes Labialis | 3 | 2010 | 29 | 0.800 |
Why?
|
| Jaw Neoplasms | 3 | 2015 | 76 | 0.790 |
Why?
|
| Diagnosis, Oral | 2 | 2014 | 26 | 0.790 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2021 | 4038 | 0.770 |
Why?
|
| Maxillary Neoplasms | 2 | 2020 | 50 | 0.770 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2019 | 75 | 0.760 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 169 | 0.710 |
Why?
|
| Triamcinolone Acetonide | 3 | 2019 | 104 | 0.710 |
Why?
|
| Pemphigoid, Benign Mucous Membrane | 2 | 2019 | 124 | 0.690 |
Why?
|
| Candidiasis, Oral | 2 | 2016 | 55 | 0.690 |
Why?
|
| Immunosuppressive Agents | 6 | 2018 | 4208 | 0.680 |
Why?
|
| Lip Neoplasms | 2 | 2011 | 40 | 0.680 |
Why?
|
| Jaw Cysts | 2 | 2015 | 9 | 0.670 |
Why?
|
| Salivary Ducts | 1 | 2017 | 24 | 0.640 |
Why?
|
| Hyperplasia | 5 | 2022 | 1173 | 0.640 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 12 | 2018 | 5152 | 0.640 |
Why?
|
| Leukoplakia | 3 | 2020 | 19 | 0.640 |
Why?
|
| Lipoma | 2 | 2018 | 335 | 0.630 |
Why?
|
| Humans | 177 | 2022 | 717280 | 0.630 |
Why?
|
| Xerostomia | 3 | 2020 | 104 | 0.630 |
Why?
|
| Middle Aged | 90 | 2021 | 215054 | 0.630 |
Why?
|
| Aged | 75 | 2022 | 162862 | 0.610 |
Why?
|
| Erythema | 1 | 2018 | 264 | 0.610 |
Why?
|
| Female | 113 | 2022 | 377934 | 0.610 |
Why?
|
| Pemphigoid, Bullous | 2 | 2019 | 103 | 0.610 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2013 | 543 | 0.590 |
Why?
|
| Male | 104 | 2022 | 351399 | 0.590 |
Why?
|
| Leukoplakia, Hairy | 3 | 2021 | 10 | 0.580 |
Why?
|
| Dental Care | 2 | 2019 | 258 | 0.570 |
Why?
|
| Biopsy | 11 | 2021 | 6753 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 380 | 0.560 |
Why?
|
| Aged, 80 and over | 38 | 2021 | 58528 | 0.560 |
Why?
|
| Gingivitis | 3 | 2019 | 123 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2022 | 3016 | 0.540 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 533 | 0.530 |
Why?
|
| Adult | 68 | 2021 | 212470 | 0.510 |
Why?
|
| Sialometaplasia, Necrotizing | 2 | 2012 | 6 | 0.490 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2013 | 78 | 0.490 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2015 | 243 | 0.490 |
Why?
|
| Neurofibroma | 1 | 2013 | 97 | 0.490 |
Why?
|
| Imidazoles | 4 | 2016 | 1273 | 0.470 |
Why?
|
| Sublingual Gland Neoplasms | 1 | 2012 | 2 | 0.470 |
Why?
|
| Granulomatosis, Orofacial | 1 | 2012 | 2 | 0.470 |
Why?
|
| Epistaxis | 1 | 2013 | 108 | 0.470 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2013 | 66 | 0.470 |
Why?
|
| Durapatite | 1 | 2013 | 163 | 0.460 |
Why?
|
| Glucocorticoids | 5 | 2019 | 2108 | 0.450 |
Why?
|
| Immunocompromised Host | 2 | 2016 | 880 | 0.450 |
Why?
|
| Carrier State | 1 | 2016 | 540 | 0.450 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 397 | 0.440 |
Why?
|
| Bronchiectasis | 1 | 2013 | 131 | 0.440 |
Why?
|
| Cysts | 1 | 2017 | 639 | 0.440 |
Why?
|
| Skull Base Neoplasms | 1 | 2015 | 277 | 0.440 |
Why?
|
| Intubation | 1 | 2012 | 140 | 0.440 |
Why?
|
| Absorbable Implants | 1 | 2014 | 338 | 0.430 |
Why?
|
| Craniofacial Abnormalities | 2 | 2014 | 326 | 0.430 |
Why?
|
| Hyperpigmentation | 2 | 2020 | 98 | 0.430 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 13754 | 0.420 |
Why?
|
| Pigmentation Disorders | 1 | 2011 | 107 | 0.420 |
Why?
|
| Foreign-Body Migration | 1 | 2013 | 228 | 0.420 |
Why?
|
| Xanthomatosis | 1 | 2011 | 34 | 0.420 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2013 | 152 | 0.410 |
Why?
|
| Fibroma | 2 | 2017 | 214 | 0.410 |
Why?
|
| Mouth Rehabilitation | 1 | 2010 | 8 | 0.410 |
Why?
|
| Bone Marrow | 1 | 2021 | 2959 | 0.410 |
Why?
|
| Salivary Glands, Minor | 2 | 2013 | 29 | 0.410 |
Why?
|
| Bacteremia | 2 | 2017 | 973 | 0.410 |
Why?
|
| Tooth Abnormalities | 1 | 2010 | 49 | 0.400 |
Why?
|
| Fatty Alcohols | 1 | 2010 | 22 | 0.400 |
Why?
|
| Tumor Virus Infections | 1 | 2013 | 457 | 0.400 |
Why?
|
| Dental Caries | 3 | 2012 | 436 | 0.390 |
Why?
|
| Melanosis | 2 | 2008 | 74 | 0.390 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 462 | 0.390 |
Why?
|
| Maxillary Diseases | 2 | 2010 | 52 | 0.390 |
Why?
|
| Biological Factors | 3 | 2022 | 164 | 0.390 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 227 | 0.390 |
Why?
|
| Pneumonia, Bacterial | 1 | 2013 | 316 | 0.390 |
Why?
|
| Papillomaviridae | 2 | 2014 | 1144 | 0.380 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2014 | 413 | 0.380 |
Why?
|
| Transplantation Conditioning | 3 | 2017 | 1573 | 0.380 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2113 | 0.380 |
Why?
|
| Granuloma | 1 | 2012 | 331 | 0.370 |
Why?
|
| Dental Fistula | 1 | 2009 | 13 | 0.370 |
Why?
|
| Automatism | 1 | 2009 | 8 | 0.370 |
Why?
|
| Radiography, Panoramic | 3 | 2015 | 115 | 0.370 |
Why?
|
| Coagulation Protein Disorders | 1 | 2008 | 6 | 0.370 |
Why?
|
| Nose | 1 | 2013 | 495 | 0.370 |
Why?
|
| Dwarfism | 1 | 2010 | 148 | 0.370 |
Why?
|
| Streptococcal Infections | 1 | 2014 | 645 | 0.360 |
Why?
|
| Lip Diseases | 2 | 2012 | 22 | 0.360 |
Why?
|
| Quinacrine | 1 | 2008 | 30 | 0.360 |
Why?
|
| Granular Cell Tumor | 2 | 2014 | 52 | 0.360 |
Why?
|
| Mouthwashes | 4 | 2021 | 46 | 0.360 |
Why?
|
| Plasminogen | 1 | 2008 | 151 | 0.350 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 73 | 0.340 |
Why?
|
| Collagen | 2 | 2014 | 2694 | 0.340 |
Why?
|
| Neurodermatitis | 1 | 2008 | 11 | 0.340 |
Why?
|
| Lactic Acid | 1 | 2013 | 1126 | 0.340 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2008 | 64 | 0.330 |
Why?
|
| Paresthesia | 2 | 2020 | 165 | 0.330 |
Why?
|
| Retrospective Studies | 35 | 2022 | 72608 | 0.330 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 500 | 0.330 |
Why?
|
| Adolescent | 32 | 2021 | 85143 | 0.320 |
Why?
|
| Administration, Topical | 5 | 2018 | 704 | 0.320 |
Why?
|
| Keratinocytes | 4 | 2021 | 802 | 0.320 |
Why?
|
| Odontogenic Cysts | 2 | 2020 | 43 | 0.310 |
Why?
|
| Clonazepam | 2 | 2017 | 142 | 0.310 |
Why?
|
| Antiviral Agents | 4 | 2014 | 2797 | 0.310 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2594 | 0.300 |
Why?
|
| Polyps | 1 | 2007 | 182 | 0.300 |
Why?
|
| Acyclovir | 1 | 2007 | 272 | 0.290 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 415 | 0.290 |
Why?
|
| Heart Valves | 1 | 2008 | 294 | 0.290 |
Why?
|
| Polymers | 1 | 2013 | 1630 | 0.290 |
Why?
|
| Republic of Korea | 9 | 2020 | 584 | 0.280 |
Why?
|
| Salivary Glands | 3 | 2019 | 235 | 0.280 |
Why?
|
| Valine | 1 | 2007 | 427 | 0.280 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 76 | 0.270 |
Why?
|
| Young Adult | 24 | 2021 | 56249 | 0.270 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 1720 | 0.270 |
Why?
|
| Pain Measurement | 3 | 2012 | 3513 | 0.270 |
Why?
|
| Periodontal Diseases | 1 | 2008 | 418 | 0.270 |
Why?
|
| Herpesvirus 4, Human | 4 | 2021 | 1257 | 0.260 |
Why?
|
| Dyskeratosis Congenita | 1 | 2004 | 74 | 0.260 |
Why?
|
| Parotid Neoplasms | 1 | 2005 | 162 | 0.250 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 436 | 0.250 |
Why?
|
| Osteoradionecrosis | 2 | 2017 | 56 | 0.250 |
Why?
|
| Minocycline | 1 | 2004 | 161 | 0.240 |
Why?
|
| Adenoma | 2 | 2011 | 2118 | 0.240 |
Why?
|
| Gingival Neoplasms | 2 | 2019 | 22 | 0.230 |
Why?
|
| Oral Medicine | 2 | 2015 | 37 | 0.230 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2731 | 0.220 |
Why?
|
| Tooth, Impacted | 2 | 2015 | 42 | 0.220 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 296 | 0.220 |
Why?
|
| Stomatitis, Herpetic | 2 | 2014 | 15 | 0.220 |
Why?
|
| Radiography | 10 | 2018 | 7000 | 0.220 |
Why?
|
| Antimalarials | 1 | 2008 | 870 | 0.220 |
Why?
|
| Prevalence | 12 | 2017 | 14899 | 0.210 |
Why?
|
| Prednisone | 4 | 2014 | 1548 | 0.210 |
Why?
|
| Chewing Gum | 1 | 2021 | 44 | 0.210 |
Why?
|
| Pathology, Oral | 1 | 2021 | 4 | 0.210 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 713 | 0.210 |
Why?
|
| Mandible | 2 | 2021 | 728 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2013 | 732 | 0.200 |
Why?
|
| Piperazines | 1 | 2011 | 2543 | 0.200 |
Why?
|
| Sarcoma, Myeloid | 1 | 2021 | 57 | 0.200 |
Why?
|
| Periapical Diseases | 2 | 2012 | 26 | 0.200 |
Why?
|
| Lymphocytosis | 1 | 2021 | 122 | 0.200 |
Why?
|
| Anti-Ulcer Agents | 1 | 2021 | 115 | 0.200 |
Why?
|
| Immunohistochemistry | 8 | 2018 | 11777 | 0.200 |
Why?
|
| Tooth Extraction | 3 | 2011 | 214 | 0.190 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2020 | 80 | 0.190 |
Why?
|
| Child | 18 | 2021 | 74388 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2014 | 3179 | 0.190 |
Why?
|
| Tobacco, Smokeless | 1 | 2021 | 127 | 0.190 |
Why?
|
| Warfarin | 1 | 2008 | 1458 | 0.190 |
Why?
|
| Hearing Loss | 2 | 2017 | 714 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2011 | 2974 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 2745 | 0.180 |
Why?
|
| Heart Valve Prosthesis | 1 | 2008 | 1499 | 0.180 |
Why?
|
| Dexamethasone | 2 | 2018 | 1952 | 0.180 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 776 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 2570 | 0.170 |
Why?
|
| False Negative Reactions | 1 | 2019 | 605 | 0.170 |
Why?
|
| Algorithms | 2 | 2016 | 13716 | 0.170 |
Why?
|
| Adipocytes | 1 | 2005 | 1185 | 0.170 |
Why?
|
| Pemphigus | 1 | 2019 | 123 | 0.170 |
Why?
|
| Otoscopy | 1 | 2017 | 35 | 0.160 |
Why?
|
| Lung | 2 | 2013 | 9781 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2021 | 513 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 1487 | 0.160 |
Why?
|
| Atrophy | 1 | 2022 | 1509 | 0.160 |
Why?
|
| Sjogren's Syndrome | 1 | 2019 | 239 | 0.160 |
Why?
|
| Gingival Hyperplasia | 2 | 2015 | 18 | 0.160 |
Why?
|
| Severity of Illness Index | 6 | 2013 | 16020 | 0.160 |
Why?
|
| Injections, Intralesional | 2 | 2019 | 282 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 1801 | 0.160 |
Why?
|
| Tacrolimus | 2 | 2018 | 715 | 0.150 |
Why?
|
| Necrosis | 1 | 2021 | 1650 | 0.150 |
Why?
|
| Alendronate | 2 | 2010 | 175 | 0.150 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 161 | 0.150 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 32 | 0.150 |
Why?
|
| Cementoma | 1 | 2015 | 5 | 0.150 |
Why?
|
| Epithelium | 1 | 2021 | 1736 | 0.150 |
Why?
|
| Sodium Tetradecyl Sulfate | 1 | 2015 | 13 | 0.150 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2017 | 161 | 0.150 |
Why?
|
| Dental Cementum | 1 | 2015 | 54 | 0.150 |
Why?
|
| Antigens, CD | 2 | 2018 | 4157 | 0.150 |
Why?
|
| Odontogenesis | 1 | 2015 | 69 | 0.150 |
Why?
|
| Ossicular Replacement | 1 | 2015 | 12 | 0.140 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 1779 | 0.140 |
Why?
|
| Semaphorins | 1 | 2016 | 117 | 0.140 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 596 | 0.140 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 1476 | 0.140 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2015 | 47 | 0.140 |
Why?
|
| Oral Health | 2 | 2019 | 438 | 0.140 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 18 | 0.140 |
Why?
|
| Periodontium | 1 | 2015 | 91 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2120 | 0.140 |
Why?
|
| Bone Matrix | 1 | 2015 | 118 | 0.140 |
Why?
|
| Neck Dissection | 1 | 2017 | 219 | 0.140 |
Why?
|
| Liposarcoma | 1 | 2018 | 316 | 0.140 |
Why?
|
| Fibroma, Ossifying | 1 | 2015 | 18 | 0.140 |
Why?
|
| Risk Factors | 19 | 2021 | 70863 | 0.140 |
Why?
|
| Follow-Up Studies | 12 | 2016 | 39302 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 269 | 0.140 |
Why?
|
| Edema | 1 | 2019 | 766 | 0.140 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 4312 | 0.140 |
Why?
|
| Postoperative Complications | 3 | 2014 | 15126 | 0.140 |
Why?
|
| Tympanoplasty | 1 | 2015 | 80 | 0.140 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12484 | 0.140 |
Why?
|
| Drug Compounding | 1 | 2016 | 246 | 0.130 | |